Expression and functional role of α7 nicotinic receptor in human cytokine-stimulated natural killer (NK) cells

Journal of Biological Chemistry

Volumn 291, Issue 32, 2016, Pages 16541-16552

  Zanetti, Samanta R ^a   Ziblat, Andrea ^b   Torres, Nicolás I ^b   Zwirner, Norberto W ^b,c   Bouzat, Cecilia ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

^b CONICET ^*  (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELL MEMBRANES; CYTOTOXICITY; ENZYME ACTIVITY; IMMUNE SYSTEM; MODULATORS;

ADAPTIVE IMMUNE RESPONSE; CELL SURFACE EXPRESSION; CENTRAL NERVOUS SYSTEMS; CYTOTOXIC ACTIVITIES; DENDRITIC CELLS (DCS); INTRACELLULAR CALCIUM CONCENTRATION; NATURAL KILLER CELLS; POSITIVE ALLOSTERIC MODULATOR;

CALCIUM COMPOUNDS;

4 CHLORO N (3 QUINUCLIDINYL)BENZAMIDE; ALPHA BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; CALCIUM ION; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; MESSENGER RNA; NATURAL KILLER CELL RECEPTOR NKG2D; BENZAMIDE DERIVATIVE; BRIDGED BICYCLO COMPOUNDS; CYTOKINE; KLRK1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; PNU-282987;

ALLOSTERISM; ALPHA7 NACHR GENE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL MATURATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CALCIUM SIGNALING; CYTOLOGY; DRUG EFFECT; FEMALE; IMMUNOLOGY; MALE;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; BENZAMIDES; BRIDGED BICYCLO COMPOUNDS; CALCIUM SIGNALING; CYTOKINES; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; NF-KAPPA B; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K;

EID: 84982862117     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.710574     Document Type: Article

References (77)

1. Bouzat, C. (2012) New insights into the structural bases of activation of Cys-loop receptors. J. Physiol. Paris 106, 23-33
2. Unwin, N. (2005) Refined structure of the nicotinic acetylcholine receptor at 4-Å resolution. J. Mol. Biol. 346, 967-989
3. Albuquerque, E. X., Pereira, E. F., Alkondon, M., and Rogers, S. W. (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev. 89, 73-120
4. Chernyavsky, A. I., Arredondo, J., Marubio, L. M., and Grando, S. A. (2004) Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic receptor subtypes. J. Cell Sci. 117, 5665-5679
5. Fasoli, F., and Gotti, C. (2015) Structure of neuronal nicotinic receptors. Curr. Top. Behav. Neurosci. 23, 1-17
6. Shen, J. X., and Yakel, J. L. (2009) Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system. Acta Pharmacol. Sin. 30, 673-680
7. Andersen, N., Corradi, J., Sine, S. M., and Bouzat, C. (2013) Stoichiometry for activation of neuronal α7 nicotinic receptors. Proc. Natl. Acad. Sci. U.S.A. 110, 20819-20824
8. De Rosa, M. J., Dionisio, L., Agriello, E., Bouzat, C., and Esandi Mdel, C. (2009) α7 nicotinic acetylcholine receptor modulates lymphocyte activation. Life Sci. 85, 444-449
9. De Rosa, M. J., Esandi Mdel, C., Garelli, A., Rayes, D., and Bouzat, C. (2005) Relationship between α7 nAChR and apoptosis in human lymphocytes. J. Neuroimmunol. 160, 154-161
10. Kawashima, K., and Fujii, T. (2004) Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front. Biosci. 9, 2063-2085
11. Kawashima, K., Fujii, T., Moriwaki, Y., and Misawa, H. (2012) Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function. Life Sci. 91, 1027-1032
12. Bencherif, M., Lippiello, P. M., Lucas, R., and Marrero, M. B. (2011) α7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol. Life Sci. 68, 931-949
13. de Jonge, W. J., and Ulloa, L. (2007) The α7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br. J. Pharmacol. 151, 915-929
14. Filippini, P., Cesario, A., Fini, M., Locatelli, F., and Rutella, S. (2012) The Yin and Yang of non-neuronal α7-nicotinic receptors in inflammation and autoimmunity. Curr. Drug Targets 13, 644-655
15. Nizri, E., and Brenner, T. (2013) Modulation of inflammatory pathways by the immune cholinergic system. Amino Acids 45, 73-85
16. Pohanka, M. (2012) α7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology. Int. J. Mol. Sci. 13, 2219-2238
17. Tracey, K. J. (2009) Reflex control of immunity. Nat. Rev. Immunol. 9, 418-428
18. Campbell, K. S., and Hasegawa, J. (2013) Natural killer cell biology: an update and future directions. J. Allergy Clin. Immunol. 132, 536-544
19. Poggi, A., and Zocchi, M. R. (2014) NK cell autoreactivity and autoimmune diseases. Front. Immunol. 5, 27
20. Ferlazzo, G., and Morandi, B. (2014) Cross-talks between natural killer cells and distinct subsets of dendritic cells. Front. Immunol. 5, 159
21. Barreira da Silva, R., and Münz, C. (2011) Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals. Cell Mol. Life Sci. 68, 3505-3518
22. Ferlazzo, G., and Münz, C. (2009) Dendritic cell interactions with NK cells from different tissues. J. Clin. Immunol. 29, 265-273
23. Zwirner, N. W., and Domaica, C. I. (2010) Cytokine regulation of natural killer cell effector functions. Biofactors 36, 274-288
24. Fogel, L. A., Yokoyama, W. M., and French, A. R. (2013) Natural killer cells in human autoimmune disorders. Arthritis Res. Ther. 15, 216
25. Tian, Z., Gershwin, M. E., and Zhang, C. (2012) Regulatory NK cells in autoimmune disease. J. Autoimmun. 39, 206-215
26. Shifrin, N., Raulet, D. H., and Ardolino, M. (2014) NK cell self tolerance, responsiveness and missing self recognition. Semin. Immunol. 26, 138-144
27. Hsueh, C. M., Chen, S. F., Lin, R. J., and Chao, H. J. (2002) Cholinergic and serotonergic activities are required in triggering conditioned NK cell response. J. Neuroimmunol. 123, 102-111
28. Qiu, Y. H., Peng, Y. P., Jiang, J. L., and Wang, J. J. (2004) Effect of acetylcholine on in vitro IL-2 production and NK cell cytotoxicity of rats. Lymphology 37, 31-38
29. Hao, J., Shi, F. D., Abdelwahab, M., Shi, S. X., Simard, A., Whiteaker, P., Lukas, R., and Zhou, Q. (2013) Nicotinic receptor β2 determines NK cell-dependent metastasis in a murine model of metastatic lung cancer. PLoS ONE 8, e57495
30. Chernyavsky, A. I., Arredondo, J., Galitovskiy, V., Qian, J., and Grando, S. A. (2009) Structure and function of the nicotinic arm of acetylcholine regulatory axis in human leukemic T cells. Int. J. Immunopathol. Pharmacol. 22, 461-472
31. Landais, E., Liautaud-Roger, F., and Antonicelli, F. (2010) Lymphocytes prime activation is required for nicotine-induced calcium waves. Front. Biosci. 2, 928-939
32. Qian, J., Galitovskiy, V., Chernyavsky, A. I., Marchenko, S., and Grando, S. A. (2011) Plasticity of the murine spleen T-cell cholinergic receptors and their role in in vitro differentiation of naive CD4 T cells toward the Th1, Th2 and Th17 lineages. Genes Immun. 12, 222-230
33. Chijioke, O., and Münz, C. (2013) Dendritic cell derived cytokines in human natural killer cell differentiation and activation. Front. Immunol. 4, 365
34. Romee, R., Leong, J. W., and Fehniger, T. A. (2014) Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer. Scientifica 2014, 205796
35. daCosta, C. J., Free, C. R., Corradi, J., Bouzat, C., and Sine, S. M. (2011) Single-channel and structural foundations of neuronal α7 acetylcholine receptor potentiation. J. Neurosci. 31, 13870-13879
36. Lam, R. A., Chwee, J. Y., Le Bert, N., Sauer, M., Pogge von Strandmann, E., and Gasser, S. (2013) Regulation of self-ligands for activating natural killer cell receptors. Ann. Med. 45, 384-394
37. Mistry, A. R., and O'Callaghan, C. A. (2007) Regulation of ligands for the activating receptor NKG2D. Immunology 121, 439-447
38. Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., Al-Abed, Y., Wang, H., Metz, C., Miller, E. J., Tracey, K. J., and Ulloa, L. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10, 1216-1221
39. Kawashima, K., and Fujii, T. (2003) The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci. 74, 675-696
40. Sun, Z., Smyth, K., Garcia, K., Mattson, E., Li, L., and Xiao, Z. (2013) Nicotine inhibits memory CTL programming. PLoS ONE 8, e68183
41. Hao, J., Simard, A. R., Turner, G. H., Wu, J., Whiteaker, P., Lukas, R. J., and Shi, F. D. (2011) Attenuation of CNS inflammatory responses by nicotine involves α7 and non-α7 nicotinic receptors. Exp. Neurol. 227, 110-119
42. Simard, A. R., Gan, Y., St-Pierre, S., Kousari, A., Patel, V., Whiteaker, P., Morley, B. J., Lukas, R. J., and Shi, F. D. (2013) Differential modulation of EAE by α9∗- and β2∗-nicotinic acetylcholine receptors. Immunol. Cell Biol. 91, 195-200
43. Hoogduijn, M. J., Cheng, A., and Genever, P. G. (2009) Functional nicotinic and muscarinic receptors on mesenchymal stem cells. Stem Cells Dev. 18, 103-112
44. Wu, J. C., Chruscinski, A., De Jesus Perez, V. A., Singh, H., Pitsiouni, M., Rabinovitch, M., Utz, P. J., and Cooke, J. P. (2009) Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor. J. Cell Biochem. 108, 433-446
45. 2+ response. J. Immunol. 179, 2889-2898
46. Schedel, A., Thornton, S., Schloss, P., Klüter, H., and Bugert, P. (2011) Human platelets express functional α7-nicotinic acetylcholine receptors. Arterioscler. Thromb. Vasc. Biol. 31, 928-934
47. Dajas-Bailador, F., and Wonnacott, S. (2004) Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 25, 317-324
48. Sharma, G., and Vijayaraghavan, S. (2002) Nicotinic receptor signaling in nonexcitable cells. J. Neurobiol. 53, 524-534
49. Mandal, A., and Viswanathan, C. (2015) Natural killer cells: in health and disease. Hematol. Oncol. Stem Cell Ther. 8, 47-55
50. Pavlov, V. A., and Tracey, K. J. (2005) The cholinergic anti-inflammatory pathway. Brain. Behav. Immun. 19, 493-499
51. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., and Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811
52. Banchereau, J., and Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252
53. Cella, M., Sallusto, F., and Lanzavecchia, A. (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9, 10-16
54. Egea, J., Buendia, I., Parada, E., Navarro, E., León, R., and Lopez, M. G. (2015) Anti-inflammatory role of microglial α7 nAChRs and its role in neuroprotection. Biochem. Pharmacol. 97, 463-472
55. Kalkman, H. O., and Feuerbach, D. (2016) Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders. Cell Mol. Life Sci. 73, 2511-2530
56. Hurst, R., Rollema, H., and Bertrand, D. (2013) Nicotinic acetylcholine receptors: from basic science to therapeutics. Pharmacol. Ther. 137, 22-54
57. Corradi, J., and Bouzat, C. (2016) Understanding the bases of function and modulation of α7 nicotinic receptors: implications for drug discovery. Mol. Pharmacol. 10.1124/mol.116.104240
58. Suzuki, T., Hide, I., Matsubara, A., Hama, C., Harada, K., Miyano, K., Andrä, M., Matsubayashi, H., Sakai, N., Kohsaka, S., Inoue, K., and Nakata, Y. (2006) Microglial α7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. J. Neurosci. Res. 83, 1461-1470
59. Zdanowski, R., Krzyzowska, M., Ujazdowska, D., Lewicka, A., and Lewicki, S. (2015) Role of α7 nicotinic receptor in the immune system and intracellular signaling pathways. Cent. Eur. J. Immunol. 40, 373-379
60. King, J. R., and Kabbani, N. (2016) α7 nicotinic receptor coupling to heterotrimeric G proteins modulates RhoA activation, cytoskeletal motility, and structural growth. J. Neurochem. 10.1111/jnc.13660
61. King, J. R., Nordman, J. C., Bridges, S. P., Lin, M. K., and Kabbani, N. (2015) Identification and characterization of a G protein-binding cluster in α7 nicotinic acetylcholine receptors. J. Biol. Chem. 290, 20060-20070
62. Adamczyk, M., Brashear, R. J., and Mattingly, P. G. (2006) Choline concentration in normal blood donor and cardiac troponin-positive plasma samples. Clin. Chem. 52, 2123-2124
63. Kawashima, K., Fujii, T., Moriwaki, Y., Misawa, H., and Horiguchi, K. (2015) Non-neuronal cholinergic system in regulation of immune function with a focus on α7 nAChRs. Int. Immunopharmacol. 29, 127-134
64. Lueders, C. D., Müller, O., Storm, C., and Möckel, M. (2007) Evaluation of a chemiluminescent assay for analysis of choline in human plasma and whole blood. Lab. Med. 38, 726-728
65. Pacheco, R., Riquelme, E., and Kalergis, A. M. (2010) Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands. Cent. Nerv. Syst. Agents Med. Chem. 10, 65-83
66. Weinstein, L. I., Revuelta, A., and Pando, R. H. (2015) Catecholamines and acetylcholine are key regulators of the interaction between microbes and the immune system. Ann. N.Y. Acad. Sci. 1351, 39-51
67. Mignini, F., Streccioni, V., and Amenta, F. (2003) Autonomic innervation of immune organs and neuroimmune modulation. Auton. Autacoid Pharmacol. 23, 1-25
68. 2+ optimum. Adv. Exp. Med. Biol. 740, 603-638
69. Uteshev, V. V. (2014) The therapeutic promise of positive allosteric modulation of nicotinic receptors. Eur. J. Pharmacol. 727, 181-185
70. Arredondo, J., Chernyavsky, A. I., Webber, R. J., and Grando, S. A. (2005) Biological effects of SLURP-1 on human keratinocytes. J. Invest. Dermatol. 125, 1236-1241
71. Chimienti, F., Hogg, R. C., Plantard, L., Lehmann, C., Brakch, N., Fischer, J., Huber, M., Bertrand, D., and Hohl, D. (2003) Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Hum. Mol. Genet. 12, 3017-3024
72. Kawashima, K., Fujii, T., Moriwaki, Y., Misawa, H., and Horiguchi, K. (2012) Reconciling neuronally and nonneuronally derived acetylcholine in the regulation of immune function. Ann. N.Y. Acad. Sci. 1261, 7-17
73. Chatzidaki, A., and Millar, N. S. (2015) Allosteric modulation of nicotinic acetylcholine receptors. Biochem. Pharmacol. 97, 408-417
74. Williams, D. K., Wang, J., and Papke, R. L. (2011) Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations. Biochem. Pharmacol. 82, 915-930
75. Domaica, C. I., Fuertes, M. B., Uriarte, I., Girart, M. V., Sardañons, J., Comas, D. I., Di Giovanni, D., Gaillard, M. I., Bezrodnik, L., and Zwirner, N. W. (2012) Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development. PLoS ONE 7, e51677
76. Ziblat, A., Domaica, C. I., Spallanzani, R. G., Iraolagoitia, X. L., Rossi, L. E., Avila, D. E., Torres, N. I., Fuertes, M. B., and Zwirner, N. W. (2015) IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur. J. Immunol. 45, 192-202
77. Rossi, L. E., Avila, D. E., Spallanzani, R. G., Ziblat, A., Fuertes, M. B., Lapyckyj, L., Croci, D. O., Rabinovich, G. A., Domaica, C. I., and Zwirner, N. W. (2012) Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression. J. Leukoc. Biol. 91, 321-331